Note: While Mounjaro side effects are expected when beginning treatment and during each dose increase, titration can reduce this
Obesity and visceral adiposity are key drivers of HFpEF development and progression, and this may be even more amplified in women, who represent the majority of people with the disease, and bear a heavier burden of symptoms and physical limitations due to HFpEF
Ma W, Heianza Y, Huang T, Wang T, Sun D, Zheng Y, et al
These are common adverse effects, especially during dose escalation phases
Short-term resveratrol treatment restored the quality of oocytes in aging mice
Muscle weakness: Is It linked to Ozempic